Annual Meeting of The Endocrine Society (ENDO 2021)

Virtual 20 March 2021 - 23 March 2021

Paediatric adrenal insufficiency, T1D may impact COVID-19 outcomes

18 May 2021 by

Children who have adrenal insufficiency or type 1 diabetes (T1D) may have a higher likelihood of mortality and certain complications of COVID-19, according to research presented at ENDO 2021.

Paediatric adrenal insufficiency, T1D may impact COVID-19 outcomes

18 May 2021

BIO89-100 reduces liver fat in NASH

27 Apr 2021 by

Weekly (QW) or biweekly (Q2W) treatment with BIO89-100 led to a significantly reduced liver fat and liver fat volume (LFV) in patients with nonalcoholic steatohepatitis (NASH), according to a recent study presented at ENDO 2021.

BIO89-100 reduces liver fat in NASH

27 Apr 2021

Ertugliflozin: A suitable add-on for inadequately controlled T2D

23 Apr 2021 by

Ertugliflozin may be a suitable add-on therapy in patients with type 2 diabetes mellitus (T2DM) and established atherosclerotic cardiovascular disease (ASCVD) whose glucose levels are inadequately controlled by a metformin-sulfonylurea or insulin regimen, substudies of the phase III VERTIS* CV trial showed.

Ertugliflozin: A suitable add-on for inadequately controlled T2D

23 Apr 2021

Early breakfast may improve insulin resistance

22 Apr 2021 by

Adults who took their first meal before 8:30 am had better insulin resistance than those who did so after 8:30 am, independent of eating duration, according to a study presented at ENDO 2021.

Early breakfast may improve insulin resistance

22 Apr 2021

Male phenotype of PCOS uncovered; risks of T2D, CVD likely

15 Apr 2021 by

New evidence from a recent trial points to a genetically defined male equivalent of PCOS* that is characterized by ovarian-independent pathogenesis and can increase risks for excess weight, type 2 diabetes (T2D), and cardiovascular disease (CVD) in men, reports an expert at ENDO 2021.

Male phenotype of PCOS uncovered; risks of T2D, CVD likely

15 Apr 2021

Patients, doctors to continue using telemedicine postpandemic

15 Apr 2021 by

Patients and healthcare practitioners in the endocrinology setting seem satisfied with the use of telemedicine, and most say that they would want to maintain such a system even after the novel coronavirus disease (COVID-19) pandemic, according to a study presented at the recently concluded ENDO 2021 virtual conference by the Endocrine Society.

Patients, doctors to continue using telemedicine postpandemic

15 Apr 2021

Abnormal blood sodium levels may indicate COVID-19 severity

14 Apr 2021 by

In patients hospitalized with COVID-19, hypernatraemia during hospitalization may increase mortality risk, while hyponatraemia at admission may up the need for ventilation support, a recent study from the UK showed.

Abnormal blood sodium levels may indicate COVID-19 severity

14 Apr 2021

Sequential therapy beefs up bone density in women with anorexia

14 Apr 2021 by

Administering recombinant human insulin-like growth hormone-1 (rhIGF-1) for 6 months followed by risedronate for another 6 months helps improve bone mineral density (BMD) at the spine in women with anorexia nervosa, according to a study.

Sequential therapy beefs up bone density in women with anorexia

14 Apr 2021

AM833 plus semaglutide safe, trims weight in obese/overweight individuals

14 Apr 2021 by

The combination of long-acting amylin analogue AM833 (at all tested doses) and glucagon-like peptide-1 receptor agonist semaglutide (2.4 mg) is well tolerated and shows an acceptable safety profile, with pharmacokinetics data supporting once-weekly dosing, according to a study presented at the virtual conference of the Endocrine Society (ENDO 2021).

AM833 plus semaglutide safe, trims weight in obese/overweight individuals

14 Apr 2021

PCOS in men? Genetic study uncovers disease pathways common to both sexes

14 Apr 2021 by

Genetic risk factors of polycystic ovary syndrome (PCOS) also induce a similar condition in men, suggesting that PCOS is not always and necessarily a disorder of women’s reproductive systems, according to a new study presented at the recently concluded ENDO 2021 virtual conference by the Endocrine Society.

PCOS in men? Genetic study uncovers disease pathways common to both sexes

14 Apr 2021